Patient-Reported Outcomes in Patients with Chronic Migraine Receiving Placebo or Erenumab (AMG 334) in a Phase 2, Randomized, Double-Blind Study

被引：0

作者：

Tepper, Stewart ^{[1
]}

Lipton, Richard ^{[2
]}

Reuter, Uwe ^{[3
]}

Silberstein, Stephen ^{[4
]}

Stewart, Walter ^{[5
]}

Leonardi, Dean ^{[6
]}

Desai, Pooja ^{[7
]}

Cheng, Sunfa ^{[8
]}

Mikol, Dan ^{[8
]}

Lenz, Robert ^{[8
]}

机构：

[1] Geisel Sch Med Dartmouth, Hanover, NH USA

[2] Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA

[3] Charlie Univ Med Berlin, Dept Neurol, Berlin, Germany

[4] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA USA

[5] Sutter Hlth, Walnut Creek, CA USA

[6] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA USA

[7] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA USA

[8] Amgen Inc, Global Dev, Thousand Oaks, CA USA

来源：

NEUROLOGY | 2017年 / 88卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P2.167

引用

页数：3

共 50 条

[41] Reversion From Chronic to Episodic Migraine and Effects on Patient-reported Outcomes Following Treatment With Erenumab: Post-hoc Analysis of the Randomised, 12-week, Double-blind DRAGON Study
Wang, Shuu-Jiun
Kim, Byung-Kun
Wang, Hebo
Zhou, Jiying
Wan, Qi
Yu, Tingmin
Lian, Yajun
Arkuszewski, Michal
Ecochard, Laurent
Wen, Shihua
Yin, Fangfang
Li, Zheng
Su, Wendy
Yu, Shengyuan
CEPHALALGIA, 2022, 42 (1_SUPPL) : 29 - 31
[42] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
de Seze, J.
Montalban, X.
McDougall, F.
Sauter, A.
Deol-Bhullar, G.
Wolinsky, J.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 677 - 678
[43] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
de Seze, Jerome
Montalban, Xavier
McDougall, Fiona
Julian, Laura
Sauter, Annette
Deol-Bhullar, Gurpreet
Wolinsky, Jerry
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 84 - 84
[44] Efficacy of Erenumab (a fully human Mab targeting the CGRP receptor) in Chronic Migraine Patients with Prior Treatment Failure: a Subgroup Analysis of the Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Ashina, Messoud
Tepper, Stewart
Brandes, Jan L.
Reuter, Uwe
Boudreau, Guy
Dolezil, David
Cheng, Sunfa
Leonardi, Dean
Lenz, Robert
Klatt, Jan
Mikol, Daniel
CEPHALALGIA, 2017, 37 : 326 - 328
[45] NETAKIMAB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 TRIAL (PATERA)
Korotaeva, T.
Gaydukova, I.
Mazurov, V.
Samtsov, A.
Khayrutdinov, V.
Bakulev, A.
Kokhan, M.
Kundzer, A.
Soroka, N.
Dokukina, E.
Eremeeva, A.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1691 - 1692
[46] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Busse, W. W.
Wenzel, S. E.
Meltzer, E. O.
Kerwin, E. M.
Liu, M. C.
Zhang, N.
Chon, Y.
Lin, J.
Lin, S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
[47] Effects of Erenumab on Patient-Reported Outcomes in a Subgroup of Patients With Episodic Migraine and Severe Functional Impairment
Lipton, R. B.
Ailani, J.
Wang, A.
Meng, X.
Win, N.
Abdrabboh, A.
Chou, D. E.
Kudrow, D.
Tepper, S. J.
HEADACHE, 2020, 60 : 104 - 104
[48] Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
Witzig, TE
Silberstein, PT
Loprinzi, CL
Sloan, JA
Novotny, PJ
Mailliard, JA
Rowland, KM
Alberts, SR
Krook, JE
Levitt, R
Morton, RF
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2606 - 2617
[49] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab in Migraine Prevention: Primary Results of the ARISE Trial
Dodick, David
Ashina, Messoud
Kudrow, David
Lanteri-Minet, Michel
Osipova, Vera
Paler, Kerry
Picard, Hernan
Mikol, Daniel
Lenz, Robert
NEUROLOGY, 2017, 89 (08) : E98 - E98
[50] PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS
Habib, Ali A.
Druzdz, Artur
Grosskreutz, Julian
Kaminski, Henry
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Morel, Thomas
Boehnlein, Marion
Woltering, Franz
Bozorg, Ali
Gayfieva, Maryam
Bril, Vera
MUSCLE & NERVE, 2022, 65 : S19 - S20

← 1 2 3 4 5 →